News Sentiment

LEGN sentiment intelligence

Legend Biotech Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 66 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 27.08 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

82/100 classification confidence.

Company focus 58

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-9.5% over one week, -24.5% over four weeks, trend active, and below fair value.

Latest direct headline Neutral

Lobbying Update: $90,000 of LEGEND BIOTECH CORPORATION lobbying was just disclosed

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 82/100 classification
One-week reaction -9.5% Price reacting lower
Trend fit Trend active -24.5% over four weeks
Fair value -35.8% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 48
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 58
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 11
Stock Titan 10
TradingView 6
GuruFocus 5
simplywall.st 5
Quiver Quantitative 2
Investing.com Nigeria 2
Finviz 2

Event Lens

What the news is about

Classified themes
Market update 40
Earnings 15
Analyst action 8
Regulatory and legal 1
Balance sheet 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 66
Insider Monkey Direct company coverage

5 Best Healthcare Stocks to Buy According to Wall Street Analysts

This article identifies Legend Biotech Corporation (NASDAQ: LEGN) as one of the best healthcare stocks to buy according to Wall Street analysts, citing a price target increase by UBS and promising clinical trial results. The company's LB5006 program showed therapeutic activity an

Tone
Neutral 50/100
Event
Earnings
Published
24 Jun 2026 18:40
Source
Insider Monkey
24/7 Wall St. Direct company coverage

After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching

Following AbbVie's acquisition of Apogee Therapeutics, biotech M&A is seeing renewed interest. This article identifies three biotech companies as potential buyout targets for Wall Street: Revolution Medicines (RVMD), Structure Therapeutics (GPCR), and Legend Biotech (LEGN). Each

Tone
Positive 74/100
Event
Deals and strategy
Published
24 Jun 2026 11:55
Source
24/7 Wall St.